Aristea’s $63 Million Series B Financing Round

Wilson Sonsini Goodrich & Rosati advised Aristea Therapeutics on the deal.

Aristea announced the closing of a $63 million Series B financing led by Fidelity Management & Research Company, LLC. Existing investor Novo Holdings A/S and new investors Arena Pharmaceuticals also participated, with funds managed by Tekla Capital Management LLC.

Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory orphan diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea’s lead program, RIST4721, is currently in Phase 2 clinical development. Aristea is headquartered in San Diego, CA.

The Wilson Sonsini team advising Aristea Therapeutics in the transaction included the following attorneys: Miranda Biven (Picture), John Krocak, Colin Bosch, Sai Upadhyayula, Dan Koeppen, Jason Skolnik, Meghan Burton, 
Daniel Canavan, Kexi Wang, Dennis Grady, Michael Hostetler, Ingo Hardt, Chen Zhao, David Hoffmeister, Eva Yin, Scott McCall, Michael Klippert, Todd Hahn, Baasil Shariff, Jonathan Zhu, Derek Wallace and Nika Antonikova. 

 

 

Involved fees earner: Nika Antonikova – Wilson Sonsini Goodrich & Rosati; Miranda Biven – Wilson Sonsini Goodrich & Rosati; Colin Bosch – Wilson Sonsini Goodrich & Rosati; Meghan Burton – Wilson Sonsini Goodrich & Rosati; Daniel Canavan – Wilson Sonsini Goodrich & Rosati; Dennis Grady – Wilson Sonsini Goodrich & Rosati; Todd Hahn – Wilson Sonsini Goodrich & Rosati; Ingo Hardt – Wilson Sonsini Goodrich & Rosati; David Hoffmeister – Wilson Sonsini Goodrich & Rosati; Michael Hostetler – Wilson Sonsini Goodrich & Rosati; Michael Klippert – Wilson Sonsini Goodrich & Rosati; Dan Koeppen – Wilson Sonsini Goodrich & Rosati; John Krocak – Wilson Sonsini Goodrich & Rosati; Scott McCall – Wilson Sonsini Goodrich & Rosati; Baasil Shariff – Wilson Sonsini Goodrich & Rosati; Jason Skolnik – Wilson Sonsini Goodrich & Rosati; Saikrishna Upadhyayula – Wilson Sonsini Goodrich & Rosati; Derek Wallace – Wilson Sonsini Goodrich & Rosati; Kexi Wang – Wilson Sonsini Goodrich & Rosati; Eva Yin – Wilson Sonsini Goodrich & Rosati; Chen Zhao – Wilson Sonsini Goodrich & Rosati; Jonathan Zhu – Wilson Sonsini Goodrich & Rosati;

Law Firms: Wilson Sonsini Goodrich & Rosati;

Clients: Aristea Therapeutics;

Author: Martina Bellini